Etanercept treatment in Fanconi anaemia; combined US and Italian experience

Br J Haematol. 2012 Sep;158(6):809-11. doi: 10.1111/j.1365-2141.2012.09250.x. Epub 2012 Jul 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple
  • Anemia, Aplastic
  • Bone Marrow Diseases
  • Bone Marrow Failure Disorders
  • Child
  • Clinical Trials as Topic / statistics & numerical data*
  • Etanercept
  • Fanconi Anemia / complications
  • Fanconi Anemia / drug therapy*
  • Female
  • Hemoglobinuria, Paroxysmal / drug therapy
  • Hemoglobinuria, Paroxysmal / etiology
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Italy
  • Male
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • United States
  • Young Adult

Substances

  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept